These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33240394)

  • 1. Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn's disease.
    Qiu X; Zhao X; Cui X; Mao X; Tang N; Jiao C; Wang D; Zhang Y; Ye Z; Zhang H
    Therap Adv Gastroenterol; 2020; 13():1756284820971202. PubMed ID: 33240394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
    Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
    J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease.
    He C; Wang H; Yu C; Peng C; Shu X; Liao W; Zhu Z
    Front Bioeng Biotechnol; 2021; 9():673691. PubMed ID: 34295880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
    Zhang Z; Taylor L; Shommu N; Ghosh S; Reimer R; Panaccione R; Kaur S; Hyun JE; Cai C; Deehan EC; Hotte N; Madsen KL; Raman M
    J Crohns Colitis; 2020 Nov; 14(11):1547-1557. PubMed ID: 32343765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.
    Li Q; Wang C; Tang C; He Q; Li N; Li J
    J Clin Gastroenterol; 2014 Jul; 48(6):513-23. PubMed ID: 24275714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn's disease patients, but not in healthy controls.
    Schäffler H; Herlemann DP; Klinitzke P; Berlin P; Kreikemeyer B; Jaster R; Lamprecht G
    J Dig Dis; 2018 Apr; 19(4):225-234. PubMed ID: 29573237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut Microbiota of Healthy Chilean Subjects Reveals a High Abundance of the Phylum Verrucomicrobia.
    Fujio-Vejar S; Vasquez Y; Morales P; Magne F; Vera-Wolf P; Ugalde JA; Navarrete P; Gotteland M
    Front Microbiol; 2017; 8():1221. PubMed ID: 28713349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn's disease.
    Kowalska-Duplaga K; Gosiewski T; Kapusta P; Sroka-Oleksiak A; Wędrychowicz A; Pieczarkowski S; Ludwig-Słomczyńska AH; Wołkow PP; Fyderek K
    Sci Rep; 2019 Dec; 9(1):18880. PubMed ID: 31827191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach.
    Frau A; Ijaz UZ; Slater R; Jonkers D; Penders J; Campbell BJ; Kenny JG; Hall N; Lenzi L; Burkitt MD; Pierik M; Darby AC; Probert CSJ
    Gut Microbes; 2021; 13(1):1930871. PubMed ID: 34241567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan.
    Chang TE; Luo JC; Yang UC; Huang YH; Hou MC; Lee FY
    J Chin Med Assoc; 2021 Jun; 84(6):580-587. PubMed ID: 33871395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
    Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn's Disease Patients.
    Kameli N; Becker HEF; Welbers T; Jonkers DMAE; Penders J; Savelkoul P; Stassen FR
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal microbiota dysbiosis in IBD.
    Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
    Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.
    Rashed R; Valcheva R; Dieleman LA
    Front Med (Lausanne); 2022; 9():887044. PubMed ID: 35783604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.